Market Cap (In EUR)
296.15 Million
Revenue (In EUR)
1.78 Billion
Net Income (In EUR)
18.81 Million
Avg. Volume
8911.00
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 11.51-20.6
- PE
- -
- EPS
- -
- Beta Value
- 1.056
- ISIN
- DE000A1MMCC8
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Mr. Matthias Gaertner
- Employee Count
- -
- Website
- https://www.medios.ag
- Ipo Date
- 2017-11-07
- Details
- Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
More Stocks
-
KMPB
-
2429
-
FGN
-
RBLN-BRoblon A/S
RBLN-B
-
IEXAiExalt, Inc.
IEXA
-
EDDYFEdison Lithium Corp.
EDDYF
-
3115
-
2030